Next Article in Journal
Preparation and First Preclinical Evaluation of [18F]FE@SNAP: A Potential PET Tracer for the Melanin-Concentrating Hormone Receptor-1 (MCHR1)
Previous Article in Journal
Oral Immunization Against Candidiasis Using Lactobacillus casei Displaying Enolase 1 from Candida albicans
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Biological Approach to the Synthesis of Silver Nanoparticles with Streptomyces sp JAR1 and its Antimicrobial Activity

by
Ritika CHAUHAN
,
Abhishek KUMAR
and
Jayanthi ABRAHAM
*
School of Biosciences and Technology, VIT University, Vellore, Tamil Nadu, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2013, 81(2), 607-624; https://doi.org/10.3797/scipharm.1302-02
Submission received: 5 February 2013 / Accepted: 28 March 2013 / Published: 28 March 2013

Abstract

The biological approach to synthesize metal nanoparticles is an important aspect of current nanotechnology research. Silver nanoparticles have been well-known for their inhibitory and antimicrobial effects. The ever-increasing antibiotic resistance in pathogenic and opportunistic microorganisms is a major threat to the health care industry. In the present investigation, silver nanoparticles have been successfully biosynthesized by Streptomyces sp JAR1. Biosynthesized silver nanoparticles were characterized by means of several analytical techniques including a UV-Visible spectrophotometer, Fourier transform infrared spectroscopy, X-ray diffraction pattern analysis, and atomic force microscopy. An evaluation of the antimicrobial activity of silver nanoparticles (AgNPs) was carried out against clinically important pathogenic microorganisms. The metal nanoparticles were also evaluated for their combined effects with antibiotics against the clinical pathogens. The anti-bacterial activities of the antibiotics increased in the presence of the biologically synthesized AgNPs against the clinically important pathogens. The highest enhancing effect was observed for erythromycin against the test pathogens.
Keywords: Streptomyces sp JAR1; Metal nanoparticles; Synergistic effect; Antibiotics; XRD pattern Streptomyces sp JAR1; Metal nanoparticles; Synergistic effect; Antibiotics; XRD pattern

Share and Cite

MDPI and ACS Style

CHAUHAN, R.; KUMAR, A.; ABRAHAM, J. A Biological Approach to the Synthesis of Silver Nanoparticles with Streptomyces sp JAR1 and its Antimicrobial Activity. Sci. Pharm. 2013, 81, 607-624. https://doi.org/10.3797/scipharm.1302-02

AMA Style

CHAUHAN R, KUMAR A, ABRAHAM J. A Biological Approach to the Synthesis of Silver Nanoparticles with Streptomyces sp JAR1 and its Antimicrobial Activity. Scientia Pharmaceutica. 2013; 81(2):607-624. https://doi.org/10.3797/scipharm.1302-02

Chicago/Turabian Style

CHAUHAN, Ritika, Abhishek KUMAR, and Jayanthi ABRAHAM. 2013. "A Biological Approach to the Synthesis of Silver Nanoparticles with Streptomyces sp JAR1 and its Antimicrobial Activity" Scientia Pharmaceutica 81, no. 2: 607-624. https://doi.org/10.3797/scipharm.1302-02

APA Style

CHAUHAN, R., KUMAR, A., & ABRAHAM, J. (2013). A Biological Approach to the Synthesis of Silver Nanoparticles with Streptomyces sp JAR1 and its Antimicrobial Activity. Scientia Pharmaceutica, 81(2), 607-624. https://doi.org/10.3797/scipharm.1302-02

Article Metrics

Back to TopTop